Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
In plain words A Phase 1 and 2 study of carnosine in people 40 to 80, run by Shahid Baba. It plans to enroll about 144 people at 3 US sites.
Who it lists and where
Who the trial lists, as registered
Lists people 40 to 80. Conditions: Peripheral Arterial Disease.
- Participants between 40-80 years of age.
- White or African American race.
- Literate in English.
- ABI >0.4-<0.90, obtained within 6 weeks from enrollment.
2 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Carnosine
Registered summary
The purpose of this study is to determine whether carnosine (a food ingredient found in chicken and red meat) supplementation (2 g) for 6 months in participants with non-claudication and claudication peripheral arterial disease (PAD) improves walking ability. Previous studies with heart failure patients have shown that carnosine supplementation increases walking capacity in these patients.
Where, as registered
3 US sites in 1 state.